Search Results - "Keohan, Mary Lou"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    IGF2 over-expression in solitary fibrous tumours is independent of anatomical location and is related to loss of imprinting by Hajdu, Mihai, Singer, Samuel, Maki, Robert G, Schwartz, Gary K, Keohan, Mary Lou, Antonescu, Cristina R

    Published in The Journal of pathology (01-07-2010)
    “…Solitary fibrous tumour (SFT) is a mesenchymal neoplasm composed of CD34-positive fibroblastic cells. The pathogenesis driving this neoplasm remains unclear,…”
    Get full text
    Journal Article
  2. 2

    Combined heart and lung transplantation for unresectable primary cardiac sarcoma by Talbot, Susan M., Taub, Robert N., Keohan, Mary Lou, Edwards, Niloo, Galantowicz, Mark E., Schulman, Larry L.

    “…Objective: The prognosis for patients with primary cardiac sarcoma is poor. Median survival is less than 10 months, especially when complete surgical excision…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    IGF2 Overexpression in Solitary Fibrous Tumors is Independent of Anatomic Location and is Related to Loss of Imprinting by Hajdu, Mihai, Singer, Samuel, Maki, Robert G., Schwartz, Gary K, Keohan, Mary Lou, Antonescu, Cristina R.

    Published in The Journal of pathology (01-07-2010)
    “…Solitary Fibrous Tumor (SFT) is a mesenchymal neoplasm composed of CD34-positive fibroblastic cells. The pathogenesis driving this neoplasm remains unclear,…”
    Get full text
    Journal Article
  6. 6

    Phenotype of recovering lymphoid cell populations after marrow transplantation by AULT, K. A, ANTIN, J. H, GINSBURG, D, ORKIN, S. H, RAPPEPORT, J. M, KEOHAN, M. L, MARTIN, P, SMITH, B. R

    Published in The Journal of experimental medicine (01-06-1985)
    “…Four patients who received bone marrow transplants were studied sequentially during the posttransplant period to define the pattern of recovering lymphoid cell…”
    Get full text
    Journal Article
  7. 7

    A phase II Southwest Oncology Group study of cisplatin and continuous infusion vinblastine in the treatment of advanced soft tissue sarcoma by KEOHAN, M. L, GREVER, M. R, BALCERZAK, S. P, ANTMAN, K

    Published in Investigational new drugs (01-01-1997)
    “…Bone and soft tissue sarcomas currently comprise 1% of adult malignancies and 15% of pediatric malignancies [1]. While doxorubicin and ifosfamide are active…”
    Get full text
    Journal Article